孕妇旅行者使用的含硫柳汞的丙种球蛋白可能对胎儿不安全。国家旅行咨询协调中心
[Thiomersal in gammaglobulin for pregnant travellers may not be safe for the fetus. National Coordination Center for Travel Advisory].
作者信息
Schilthuis H J, van Wijnen J H
机构信息
Vaccinatiebureau, GG&GD, Amsterdam.
出版信息
Ned Tijdschr Geneeskd. 1999 Jul 31;143(31):1622.
PMID:10488375
Abstract
It is not advisible to use thiomersal-containing gammaglobulin preparations for the prevention of hepatitis A in pregnant women. The current preparation of Sanquin-Centraal Laboratorium voor de Bloedtransfusiedienst will yield per 5 ml about 285 micrograms of ethylmercury. This exposure to ethylmercury may not be safe for the foetus and alternatives without ethylmercury are readily available.
摘要
不建议使用含硫柳汞的丙种球蛋白制剂来预防孕妇感染甲型肝炎。Sanquin-Centraal Laboratorium voor de Bloedtransfusiedienst目前生产的制剂，每5毫升约含285微克乙基汞。这种乙基汞暴露对胎儿可能不安全，且不含乙基汞的替代产品很容易获得。
相似文献
1
[Thiomersal in gammaglobulin for pregnant travellers may not be safe for the fetus. National Coordination Center for Travel Advisory].
Ned Tijdschr Geneeskd. 1999 Jul 31;143(31):1622.
2
[Thiomersal in gammaglobulins for pregnant travelers may not be safe for the fetus].
Ned Tijdschr Geneeskd. 1999 Sep 18;143(38):1934-5.
3
Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism.
Pediatrics. 2010 Oct;126(4):656-64. doi: 10.1542/peds.2010-0309. Epub 2010 Sep 13.
4
National Advisory Committee on Immunization (NACI). Statement on thimerosal.
Can Commun Dis Rep. 2003 Mar 1;29:1-10.
5
Ethylmercury in vaccines.
Pediatrics. 2003 Apr;111(4 Pt 1):922-3. doi: 10.1542/peds.111.4.922-a.
6
The evidence for the safety of thiomersal in newborn and infant vaccines.
Vaccine. 2004 May 7;22(15-16):1854-61. doi: 10.1016/j.vaccine.2003.11.017.
7
Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study.
Lancet. 2002 Nov 30;360(9347):1737-41. doi: 10.1016/S0140-6736(02)11682-5.
8
Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease.
Drug Saf. 2005;28(2):89-101. doi: 10.2165/00002018-200528020-00001.
9
Thiomersal.
Contact Dermatitis. 1979 Jan;5(1):58-9. doi: 10.1111/j.1600-0536.1979.tb05544.x.
10
When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
Expert Opin Drug Saf. 2006 Jan;5(1):17-29. doi: 10.1517/14740338.5.1.17.
引用本文的文献
1
Vaccines without thiomersal: why so necessary, why so long coming?
Drugs. 2001;61(5):565-72. doi: 10.2165/00003495-200161050-00002.
Zotero 插件